Baird Financial Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.2M | Buy |
142,953
+9,704
| +7% | +$865K | 0.02% | 513 |
|
|
2025
Q4 | $10.5M | Sell |
133,249
-14,468
| -10% | -$1.13M | 0.02% | 523 |
|
|
2025
Q3 | $11.8M | Sell |
147,717
-1,555
| -1% | -$133K | 0.02% | 497 |
|
|
2025
Q2 | $13.6M | Sell |
149,272
-15,457
| -9% | -$1.41M | 0.02% | 455 |
|
|
2025
Q1 | $15.4M | Sell |
164,729
-1,960
| -1% | -$176K | 0.03% | 413 |
|
|
2024
Q4 | $15.2M | Sell |
166,689
-1,165
| -0.7% | -$111K | 0.03% | 406 |
|
|
2024
Q3 | $17.4M | Buy |
167,854
+782
| +0.5% | +$79.7K | 0.03% | 376 |
|
|
2024
Q2 | $16.2M | Buy |
167,072
+1,823
| +1% | +$168K | 0.03% | 370 |
|
|
2024
Q1 | $14.9M | Sell |
165,249
-7,788
| -5% | -$660K | 0.03% | 393 |
|
|
2023
Q4 | $13.8M | Buy |
173,037
+3,749
| +2% | +$282K | 0.03% | 395 |
|
|
2023
Q3 | $12M | Sell |
169,288
-150,530
| -47% | -$11.3M | 0.03% | 393 |
|
|
2023
Q2 | $24.6M | Buy |
319,818
+7,974
| +3% | +$617K | 0.07% | 261 |
|
|
2023
Q1 | $23.4M | Buy |
311,844
+6,305
| +2% | +$469K | 0.06% | 277 |
|
|
2022
Q4 | $24.1M | Buy |
305,539
+10,202
| +3% | +$765K | 0.06% | 274 |
|
|
2022
Q3 | $20.7M | Sell |
295,337
-10,693
| -3% | -$838K | 0.06% | 282 |
|
|
2022
Q2 | $24.5M | Buy |
306,030
+11,468
| +4% | +$897K | 0.07% | 269 |
|
|
2022
Q1 | $22.3M | Sell |
294,562
-3,942
| -1% | -$312K | 0.06% | 295 |
|
|
2021
Q4 | $25.5M | Buy |
298,504
+7,234
| +2% | +$565K | 0.06% | 276 |
|
|
2021
Q3 | $22M | Buy |
291,270
+18,888
| +7% | +$1.5M | 0.06% | 278 |
|
|
2021
Q2 | $22.2M | Buy |
272,382
+4,377
| +2% | +$358K | 0.06% | 287 |
|
|
2021
Q1 | $21.1M | Sell |
268,005
-4,744
| -2% | -$372K | 0.06% | 286 |
|
|
2020
Q4 | $23.3M | Buy |
272,749
+1,887
| +0.7% | +$156K | 0.07% | 261 |
|
|
2020
Q3 | $20.9M | Buy |
270,862
+10,007
| +4% | +$763K | 0.07% | 260 |
|
|
2020
Q2 | $19.1M | Buy |
260,855
+593
| +0.2% | +$42.1K | 0.07% | 250 |
|
|
2020
Q1 | $17.3M | Sell |
260,262
-4,715
| -2% | -$333K | 0.08% | 243 |
|
|
2019
Q4 | $18.2M | Sell |
264,977
-9,671
| -4% | -$659K | 0.07% | 273 |
|
|
2019
Q3 | $20.2M | Sell |
274,648
-10,084
| -4% | -$732K | 0.08% | 251 |
|
|
2019
Q2 | $20.4M | Buy |
284,732
+134,310
| +89% | +$9.53M | 0.08% | 257 |
|
|
2019
Q1 | $10.3M | Sell |
150,422
-711
| -0.5% | -$45.9K | 0.06% | 315 |
|
|
2018
Q4 | $8.99M | Buy |
151,133
+106,683
| +240% | +$6.67M | 0.06% | 310 |
|
|
2018
Q3 | $2.98M | Buy |
44,450
+3,726
| +9% | +$248K | 0.02% | 572 |
|
|
2018
Q2 | $2.64M | Sell |
40,724
-1,846
| -4% | -$121K | 0.02% | 588 |
|
|
2018
Q1 | $3.05M | Buy |
42,570
+8,745
| +26% | +$629K | 0.02% | 529 |
|
|
2017
Q4 | $2.55M | Buy |
33,825
+338
| +1% | +$24.7K | 0.02% | 559 |
|
|
2017
Q3 | $2.44M | Sell |
33,487
-18,905
| -36% | -$1.36M | 0.02% | 571 |
|
|
2017
Q2 | $3.88M | Buy |
52,392
+7,214
| +16% | +$536K | 0.03% | 455 |
|
|
2017
Q1 | $3.31M | Buy |
45,178
+13,560
| +43% | +$949K | 0.03% | 480 |
|
|
2016
Q4 | $2.07M | Sell |
31,618
-1,115
| -3% | -$76.5K | 0.02% | 565 |
|
|
2016
Q3 | $2.43M | Sell |
32,733
-3,106
| -9% | -$230K | 0.02% | 518 |
|
|
2016
Q2 | $2.63M | Buy |
35,839
+784
| +2% | +$55.8K | 0.02% | 494 |
|
|
2016
Q1 | $2.48M | Sell |
35,055
-25,027
| -42% | -$1.67M | 0.02% | 488 |
|
|
2015
Q4 | $4M | Buy |
60,082
+620
| +1% | +$41.2K | 0.04% | 390 |
|
|
2015
Q3 | $3.77M | Sell |
59,462
-15,835
| -21% | -$1.03M | 0.04% | 384 |
|
|
2015
Q2 | $4.92M | Buy |
+75,297
| New | +$5.11M | 0.05% | 342 |
|
Other funds holding CL
VCM
DAM
VPM
Baird Financial Group's CL Position: Q1 2026 in Review
Baird Financial Group increased its Colgate-Palmolive (CL) stake by 7.3% in Q1 2026, buying an estimated $865K and bringing the position to 142,953 shares worth $12.2M. The position accounts for 0.02% of the portfolio, ranked #513.
Baird Financial Group first reported a position in CL in Q2 2015 and has held it in 44 quarters since. The position peaked at $25.5M in Q4 2021. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Baird Financial Group held 142,953 shares of Colgate-Palmolive worth $12.2M as of Q1 2026.
- Baird Financial Group bought 9,704 Colgate-Palmolive shares in Q1 2026, an estimated $865K.
- Colgate-Palmolive made up 0.02% of Baird Financial Group's portfolio in Q1 2026, its #513 holding.
- Baird Financial Group first reported a position in Colgate-Palmolive in Q2 2015 and has held it in 44 quarters since.
- Baird Financial Group's Colgate-Palmolive position peaked at $25.5M in Q4 2021.
- 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.